{"organizations": [], "uuid": "437405f19b1c4681b415c1ab11edbf93fc879064", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-spectracure-british-mhra-approves/brief-spectracure-british-mhra-approves-clinical-study-idUSFWN1QI0X4", "country": "US", "domain_rank": 408, "title": "BRIEF-Spectracure: British ‍MHRA Approves Clinical Study​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.947, "site_type": "news", "published": "2018-02-28T21:20:00.000+02:00", "replies_count": 0, "uuid": "437405f19b1c4681b415c1ab11edbf93fc879064"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-spectracure-british-mhra-approves/brief-spectracure-british-mhra-approves-clinical-study-idUSFWN1QI0X4", "ord_in_thread": 0, "title": "BRIEF-Spectracure: British ‍MHRA Approves Clinical Study​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mhra", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Spectracure Ab (Publ):\n* BRITISH ‍MHRA APPROVES CLINICAL STUDY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T21:20:00.000+02:00", "crawled": "2018-03-01T21:36:46.012+02:00", "highlightTitle": ""}